Cancer Research Technology
Log in Register
Menu

TERT-N-HSK cell line

Invented by Prof Aloysius Klingelhutz from The University Of Iowa
Invented at The University Of Iowa

Info

Catalogue Number 154448
Antigen/Gene or Protein Targets Used as an immortal adult human skin keratinocyte line for pathogenesis and inflammation studies
Host Human
Tissue Skin
Disease Keywords Pathogenesis and Inflammation Studies
Model Immortalised Line
Relevance Exhibits normal cellular responses
Production Details Immortalized with TERT
Conditional No
Research Area Microbiology
Growth/Phenotype Keywords normal-human skin keratinocytes
Notes useful for researchers studying diseases of the skin as they pertain to pathogenesis and inflammation

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Gourronc et al. 2010. Exp Dermatol. 19(3):279-88. PMID: 19558498.

Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA compon

Europe PMC ID: 19558498


Add a reference

References: 2 entries

Gourronc et al. 2010. Exp Dermatol. 19(3):279-88. PMID: 19558498.

Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA compon


Add a reference